BE817755A - 8-oxamorphinanes substitues en positions 3 et 14 - Google Patents

8-oxamorphinanes substitues en positions 3 et 14

Info

Publication number
BE817755A
BE817755A BE146651A BE146651A BE817755A BE 817755 A BE817755 A BE 817755A BE 146651 A BE146651 A BE 146651A BE 146651 A BE146651 A BE 146651A BE 817755 A BE817755 A BE 817755A
Authority
BE
Belgium
Prior art keywords
oxamorphinanes
substituted
positions
oxamorphinanes substituted
Prior art date
Application number
BE146651A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE817755A publication Critical patent/BE817755A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE146651A 1973-07-18 1974-07-17 8-oxamorphinanes substitues en positions 3 et 14 BE817755A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00380515A US3853889A (en) 1973-07-18 1973-07-18 3,14-substituted-8-oxamorphinans

Publications (1)

Publication Number Publication Date
BE817755A true BE817755A (fr) 1975-01-17

Family

ID=23501468

Family Applications (1)

Application Number Title Priority Date Filing Date
BE146651A BE817755A (fr) 1973-07-18 1974-07-17 8-oxamorphinanes substitues en positions 3 et 14

Country Status (13)

Country Link
US (1) US3853889A (ja)
JP (1) JPS5835197B2 (ja)
BE (1) BE817755A (ja)
CA (1) CA1029722A (ja)
CH (2) CH605963A5 (ja)
DE (1) DE2434687A1 (ja)
DK (1) DK144094C (ja)
FR (1) FR2311540A1 (ja)
GB (1) GB1473896A (ja)
NL (1) NL7409743A (ja)
SE (1) SE422581B (ja)
YU (2) YU37478B (ja)
ZA (1) ZA744492B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959290A (en) * 1973-07-18 1976-05-25 Bristol-Myers Company 3,14-Substituted-8-oxamorphinans
US3957793A (en) * 1974-09-20 1976-05-18 Sterling Drug Inc. Hydroxyiminobenzazocines
US3968114A (en) * 1974-09-20 1976-07-06 Sterling Drug Inc. 1,2,3,4,5,6,7,8,9,10-Decahydro-8-oxo-2,6-methano-3-benzazocines
US4032529A (en) * 1974-09-20 1977-06-28 Sterling Drug Inc. Aminomethanobenzazocine intermediates
US4016167A (en) * 1975-10-28 1977-04-05 Bristol-Myers Company N-Substituted-6,8-dioxamorphinans
US4127577A (en) * 1975-11-24 1978-11-28 Sterling Drug Inc. Aminomethanobenzazocine process
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
US4154932A (en) * 1977-09-08 1979-05-15 Bristol-Myers Company 6-Oxamorphinans
US4150032A (en) * 1978-01-18 1979-04-17 Bristol-Myers Company 9-Oxobenzomorphan process and intermediates
WO1980000566A1 (en) * 1978-09-12 1980-04-03 Bristol Myers Co N-substituted-6-oxamorphinans
US4234731A (en) * 1979-01-05 1980-11-18 Bristol-Myers Company 9-Oxobenzomorphan process
US4228285A (en) * 1979-02-28 1980-10-14 Bristol-Myers Company 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans
US4246413A (en) * 1979-05-14 1981-01-20 Bristol-Myers Company 6-Oxamorphinans
US4277605A (en) * 1980-03-07 1981-07-07 Bristol-Myers Company Chemical compounds
AU2003298691A1 (en) * 2002-11-18 2004-06-15 The Mclean Hospital Corporation Mixed kappa/mu opioids and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639407A (en) * 1965-05-05 1972-02-01 Geigy Chem Corp Novel 1 2 3 4 5 6-hexahydro-6-phenyl-2 6-methano-3-benzazocines
US3476757A (en) * 1966-04-18 1969-11-04 Syntex Corp Tetrahydropyranyl and tetrahydrofuranyl ethers of benzomorphans and morphanans
US3480638A (en) * 1966-11-10 1969-11-25 Geigy Chem Corp Derivatives of 5-hydroxyalkyl-6,7-benzomorphans
US3632591A (en) * 1968-07-19 1972-01-04 Sterling Drug Inc 1 2 3 4 5 6 - hexahydro-3-(cycloaliphatic or cycloaliphatic 11-dimethyl-2 alkyl)-66-methano-3-benzazocines
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
IE34235B1 (en) * 1969-06-04 1975-03-19 Acf Chemiefarma Nv 6,7-benzomorphans and their preparation
US3732233A (en) * 1970-07-23 1973-05-08 Beecham Group Ltd Tetrahydromethano benzoxazocins and salts thereof

Also Published As

Publication number Publication date
CA1029722A (en) 1978-04-18
DE2434687A1 (de) 1975-02-06
US3853889A (en) 1974-12-10
NL7409743A (nl) 1975-01-21
ZA744492B (en) 1975-07-30
YU201674A (en) 1982-06-18
AU7137574A (en) 1976-01-22
DK383874A (ja) 1975-03-03
CH605963A5 (ja) 1978-10-13
DK144094B (da) 1981-12-07
YU37346B (en) 1984-08-31
DK144094C (da) 1982-05-10
YU324080A (en) 1983-04-27
FR2311540B1 (ja) 1979-05-18
CH605962A5 (ja) 1978-10-13
SE422581B (sv) 1982-03-15
SE7409253L (ja) 1975-01-20
FR2311540A1 (fr) 1976-12-17
JPS5835197B2 (ja) 1983-08-01
JPS5048000A (ja) 1975-04-28
GB1473896A (en) 1977-05-18
YU37478B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
IT1057477B (it) Perfezionamento nelle fresse
BE807216A (fr) Analyseur d'encre et compensateur
BE817755A (fr) 8-oxamorphinanes substitues en positions 3 et 14
TR18125A (tr) Fungisid ve mikrobisid maddeler
BR7406962D0 (pt) Rotor e dispositivo incluindo o mesmo
BE831220A (fr) Phenoxybenzenes substitues et leur preparation
BE779725A (fr) Perfectionnements apportes a l'electroplacage
BE829376A (fr) Nouveaux 5,6-dimethoxyindazoles substitues en position 2
BE845187A (fr) 7-methoxy-phenyl et pyridyl-ureido-cephalosporines
BE836564A (fr) 11-desoxy-omega - pentanorprostaglandines substituees en position 15
BE825097A (fr) 4,5-diphenylthiazoles substitues en position 2 et leur synthese
BE796889A (fr) 1,2-benzisoxazoles substitues en position 3 et leur preparation
TR18322A (tr) N-n-diallildikloroasetamid'in
IT1049223B (it) Butirrammidi e butirrati
AR198136A1 (es) Mejoras en carburadores
IL44842A (en) 3 alkylamino-2-hydroxy-propoxy-phthalide and isochromanone derivatives
BE796364A (fr) O-mercaptobenzamides substitues et disulfures
BE813747A (fr) Nouvelles pyrazolones-(5) substitues en position 1
JPS5128345A (ja) In*rainhoshikihedoroshoriho
BE787372A (fr) 2-nitroamino-6-hydroxy-4-methylpyrimidines substituees en position 5
IT994899B (it) 1 2 3 4 tetraidroantrachinoni i alchil sostituiti
FR2310749A1 (fr) Nouveaux 3-amino-phenyl-1-propanols substitues en position 2
AR197921A1 (es) Mejora en silemblock
AR198969A1 (es) Mejoras en corpinos
AR195345A1 (es) Mejoras en robinetes

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19850731